Montelukast Prescribing at PATIENT FIRST SOCIAL ENTERPRISE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
22
Total Quantity
1,064
NHS Cost
£50
vs National Avg
-96.8%
PATIENT FIRST SOCIAL ENTERPRISE prescribed 22 items of Montelukast over the last 12 months at a cost of £50 to the NHS. This is 96.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 22 |
|---|---|
| Total Quantity | 1,064 |
| Total NHS Cost | £50 |
| Presentations | 2 different forms |
| vs National Average | -96.8% |
Montelukast Prescribing Comparison
| This practice | 22 items |
|---|---|
| National average per practice | 685 items |
| Difference | -96.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.